Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial
- Posted on September 8, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial
Sept 8 (Reuters) - Bristol Myers Squibb said on Tuesday its experimental cell therapy showed a high overall response rate in a mid-stage trial, in patients with a hard-to-treat form of blood cancer. The study evaluated the therapy, called arlocabtagene autoleucel, or arlo-cel, in patients with advanced multiple myeloma who had already tried four major classes of standard treatments without
